Skip to main content
. 2025 Oct 30;14(21):7724. doi: 10.3390/jcm14217724
ALK1 Activin Receptor-Like Kinase 1
ATF4 Activating Transcription Factor-4
AVMs Arteriovenous Malformations
BMP Bone Morphogenetic Protein
BOECs Blood Outgrowth Endothelial Cells
EE Ethinyl Estradiol
EMA European Medicine Agency
eNOS Endothelial NO Synthase
ENT
ER
Ear Nose Throat
Estrogen Receptor
EREs Estrogen-Responsive Elements
ERK Extracellular Signal-Regulated Kinase
ESS Epistaxis Severity Score
FDA Food and Drug Administration
FGF Fibroblast Growth Factor
HB-EGF Heparin Binding EGF Like Growth Factor
HHT Hereditary Hemorrhagic Telangiectasia
ICTRP WHO International Clinical Trials Registry Platform
IH Infantile Hemangiomas
IPF Idiopathic Pulmonary Fibrosis
IMiDs Immunomodulatory Imide Drugs
JP-HHT HHT-Juvenile Polyposis
MAPK Mitogen Activated Protein Kinase
MEK Mitogen-Activated Extracellular Signal-Regulated Kinase 1
MMPs Metalloproteinases
NAC N-acetylcysteine
NMD Nonsense Mediated Decay
PDGF-B Platelet Derived Growth Factor-B
PI3K Phosphatidyl Inositol 3-Kinase
PTC Premature Termination Codon
QoL
RCT
Quality of Life
Randomized Controlled Trial
SERM Selective Estrogen Receptor Modulator
TA Tranexamic Acid
TGF-β Transforming Growth Factor β
TKIs Tyrosine Kinase Inhibitors
TKR Tyrosine Kinase Receptors
TNFα Tumor Necrosis Factor-α
VASCERN European Reference Network on Rare Multisystemic Vascular Diseases
VEGF-A Vascular Endothelial Growth Factor-A